Krystal Biotech
- Market cap
- 9.61B
- P/E (TTM)i
- 40.67
- P/Bi
- 7.07
- EPSi
- 6.84
- Div yieldi
- 0.00%
- 52W posi
- 71%
Anonymous reader poll. Unscientific, not investment advice.
Krystal Biotech shares were changing hands at 324.57, down 0.69% on the day. At current prices, the business is worth about 9.61B, the #1515 most valuable US-listed company we track. Trading at a P/E of 40.40, the stock is 42% above its own five-year norm of 28.39. Across 9 analysts the consensus rating is Buy, with an average price target of 409.29 (+26%). Against a 52-week band of 179.19-382.54, the shares are currently 71% of the way up.
✦ StockVane Quant Insights how this is computed
- Twelve-month momentum in the top 9% of the universe, above its 200-day average.
- Signal has read BUY for 6 months.
- Its last 6 Buy calls have averaged +12% over the following quarter.
- Recent price momentum is +32.7% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 326.81
- Open
- 324.87
- Day range
- 320.20 - 330.44
- Avg price
- 325.14
- Volume
- 354.15K
- Turnover
- 115.15M
- Turnover ratei
- 1.50%
- Volume ratioi
- 1.08
- Amplitudei
- 3.14%
- 52-week rangei
- 179.19 - 382.54
Valuation
- P/Ei
- 47.45
- P/E (TTM)i
- 40.67
- P/Bi
- 7.07
- EPSi
- 6.84
- Book value / shi
- 45.92
- Net profit
- 202.46M
- Net assets
- 1.36B
Share structure
- Market cap
- 9.61B
- Float capi
- 7.67B
- Shares out
- 29.60M
- Float sharesi
- 23.62M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2017-09-20
15.2% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-10.55M net over the window
Short interest
- Shares short
- 3.16M
- % of floati
- 10.69%
- Days to coveri
- 13.23
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Krystal Biotech (KRYS)?
Krystal Biotech last traded at 324.57. The quote on this page refreshes every few seconds while US markets are open.
What is Krystal Biotech's market cap?
About 9.61B.
What is the P/E ratio of Krystal Biotech?
The trailing twelve-month P/E is 40.67, above its own 5-year average of 28.39 — toward the top of its historical range (66.64% percentile). See the Valuation tab for the full history.
Does Krystal Biotech pay a dividend?
Krystal Biotech does not currently pay a regular dividend.
Is Krystal Biotech a buy according to analysts?
The consensus of 9 analysts is a Buy rating, with an average 12-month price target of 409.29, which implies 26.1% upside from the current price. This is not investment advice.
What is Krystal Biotech's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Krystal Biotech a B (Buy). Twelve-month momentum in the top 9% of the universe, above its 200-day average. Not investment advice.
Quote time 2026-10-08 05:56:28 · For reference only, not investment advice and not tailored to your situation.